EUVIMEDEUVIMED entdecken
Crossref

Evaluation of a patient decision aid for Japanese women with BRCA1/2 pathogenic variants: A preliminary study

Megumi Okawa iD, Naoko Arimori iD

Japan Journal of Nursing Science · 2025

DOI: 10.1111/jjns.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japan Journal of Nursing Science, 2025. Verfasst von Megumi Okawa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Niigata University, Niigata, Japan. Hauptthemen laut MEDLINE: Decision Support Techniques, BRCA1 Protein, Breast Neoplasms, BRCA2 Protein. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to evaluate a decision aid for Japanese women (J‐DA) with BRCA1/2 pathogenic variants for supporting breast and ovarian cancer management decisions.

Methods

This study used a pre‐ and post‐intervention design. The participants included Japanese women with BRCA1/2 pathogenic variants who needed to make a decision regarding breast and ovarian cancer management options.

Results

All 25 participants completed the pre‐ and posttests. There was a significant reduction in the decisional conflict scale and a significant increase in the knowledge score. Significant improvements were identified in the decisional conflict scale score ( g = 0.60, p = .002) and knowledge score ( g = −1.44, p < .001). Four weeks post‐intervention, 96% of the participants had made a decision regarding the management options for breast or ovarian care.

Conclusions

The findings suggest that the decision aid (J‐DA) positively supported the decision‐making of the Japanese women with BRCA1/2 pathogenic variants. As this study apparently represents the first evaluation of a decision aid for this population, subsequent studies are anticipated to further confirm its clinical applicability and utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support TechniquesBRCA1 ProteinBreast NeoplasmsBRCA2 ProteinOvarian NeoplasmsHumansFemaleJapanMiddle AgedAdultEast Asian People

Stichwörter der Autor:innen

BRCA1 and BRCA2breast neoplasmsdecision support techniquesdecision‐makinghereditary breast and ovarian cancer syndromeovarian neoplasms

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Graduate School of Health Sciences, Niigata University, Niigata, Japan.
  • St. Luke's International Hospital, Tokyo, Japan.

ORCID-Profile: Megumi Okawa, Naoko Arimori

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Okawa, M., & Arimori, N. (2025). Evaluation of a patient decision aid for Japanese women with BRCA1/2 pathogenic variants: A preliminary study. Japan Journal of Nursing Science. https://doi.org/10.1111/jjns.70017

Vancouver

Okawa M, Arimori N. Evaluation of a patient decision aid for Japanese women with BRCA1/2 pathogenic variants: A preliminary study. Japan Journal of Nursing Science. 2025. doi:10.1111/jjns.70017

BibTeX
@article{Okawa2025,
  author = {Okawa, Megumi and Arimori, Naoko},
  title = {Evaluation of a patient decision aid for Japanese women with BRCA1/2 pathogenic variants: A preliminary study},
  journal = {Japan Journal of Nursing Science},
  year = {2025},
  doi = {10.1111/jjns.70017}
}
Kostenlos starten →